Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WASEEMULLAH KHAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1073557864
CMS profile
48213
Location
LAKE CITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$3,338.16

162 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,158.82 160
Education $179.34 2

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme LLC $201.09 10
PFIZER INC. $196.95 14
NOVARTIS PHARMACEUTICALS CORPORATION $191.64 12
Janssen Biotech, Inc. $185.24 9
AstraZeneca Pharmaceuticals LP $171.28 6
Abbott Laboratories $168.86 1
Astellas Pharma US Inc $144.06 7
Amgen Inc. $141.99 9
Takeda Pharmaceuticals U.S.A., Inc. $139.06 5
Seagen Inc. $136.47 8
Lilly USA, LLC $107.77 5
CTI BioPharma Corp. $103.26 3
Celgene Corporation $100.19 5
Gilead Sciences, Inc. $88.37 5
SERVIER PHARMACEUTICALS LLC $82.24 4
Bayer Healthcare Pharmaceuticals Inc. $81.65 4
Exelixis Inc. $80.41 4
Siemens Medical Solutions USA, Inc. $78.33 1
Genentech USA, Inc. $78.06 4
E.R. Squibb & Sons, L.L.C. $76.33 4
Stemline Therapeutics Inc. $61.91 3
Regeneron Healthcare Solutions, Inc. $54.00 3
TAIHO ONCOLOGY, INC. $49.81 3
Eisai Inc. $45.59 2
Blue Earth Diagnostics Limited $42.70 2
EMD Serono, Inc. $39.79 2
Alexion Pharmaceuticals, Inc. $37.39 2
Ipsen Biopharmaceuticals, Inc $36.36 2
G1 Therapeutics, Inc. $36.14 2
Incyte Corporation $35.84 2
GlaxoSmithKline, LLC. $35.62 2
Dendreon Pharmaceuticals LLC $32.42 1
PharmaEssentia USA Corporation $31.28 2
RECORDATI_RARE_DISEASES_INC. $29.37 1
Pharmacyclics LLC, An AbbVie Company $29.26 1
ABBVIE INC. $29.17 2
Boehringer Ingelheim Pharmaceuticals, Inc. $25.05 1
Octapharma USA, Inc. $21.04 1
Adaptive Biotechnologies Corporation $16.71 1
Heron Therapeutics, Inc. $15.26 1
SOBI, INC $14.86 1
Sumitomo Pharma America, Inc. $14.63 1
Blueprint Medicines Corporation $14.19 1
Tolmar, Inc. $13.55 1
GENZYME CORPORATION $12.97 1
Rigel Pharmaceuticals, Inc. $10.00 1

Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WASEEMULLAH KHAN

NPI 1073557864 · CMS profile ID 48213

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

LAKE CITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1073557864?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WASEEMULLAH KHAN, NPI 1073557864, CMS profile ID 48213. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1073557864?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). WASEEMULLAH KHAN, NPI 1073557864, CMS profile ID 48213. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1073557864?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
WASEEMULLAH KHAN, NPI 1073557864, CMS profile ID 48213, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1073557864?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

162 matching records · $3,338.16 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 162 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 162.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $27.5908/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032425877 CMS
SOBI, INC $14.8608/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038109925 CMS
AstraZeneca Pharmaceuticals LP $20.1208/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011450209 CMS
Janssen Biotech, Inc. $99.9908/14/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988084271 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.4808/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000690939 CMS
Alexion Pharmaceuticals, Inc. $13.1908/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016997011 CMS
G1 Therapeutics, Inc. $18.8808/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059917683 CMS
Astellas Pharma US Inc $11.2308/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034378657 CMS
Merck Sharp & Dohme LLC $20.6408/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048424123 CMS
Regeneron Healthcare Solutions, Inc. $14.3908/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999247735 CMS
SERVIER PHARMACEUTICALS LLC $20.2407/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055095181 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $13.0707/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993435271 CMS
Merck Sharp & Dohme LLC $13.1907/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048424115 CMS
PFIZER INC. $16.7107/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049410815 CMS
Seagen Inc. $21.7207/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995635429 CMS
Stemline Therapeutics Inc. $32.7707/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040041899 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.7007/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055430519 CMS
Eisai Inc. $22.3807/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023337059 CMS
CTI BioPharma Corp. $63.9007/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039697629 CMS
Janssen Biotech, Inc. $18.4407/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988084281 CMS
PharmaEssentia USA Corporation $15.7707/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059308463 CMS
Seagen Inc. $13.3507/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995635421 CMS
Lilly USA, LLC $22.5607/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032609491 CMS
PFIZER INC. $14.4107/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049326949 CMS
PFIZER INC. $1.6807/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049410821 CMS
Astellas Pharma US Inc $14.2807/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034254167 CMS
PFIZER INC. $9.4107/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049510391 CMS
PFIZER INC. $6.7207/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049307663 CMS
E.R. Squibb & Sons, L.L.C. $16.6207/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015504883 CMS
PharmaEssentia USA Corporation $15.5106/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059308431 CMS
Amgen Inc. $14.3606/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020193893 CMS
EMD Serono, Inc. $18.7806/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032541853 CMS
TAIHO ONCOLOGY, INC. $15.5806/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055228581 CMS
AstraZeneca Pharmaceuticals LP $26.2206/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015866625 CMS
Gilead Sciences, Inc. $18.4606/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025876453 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.3706/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000694337 CMS
Blue Earth Diagnostics Limited $16.6706/14/2023 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1059983927 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.7206/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055430515 CMS
AstraZeneca Pharmaceuticals LP $14.3906/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011357863 CMS
RECORDATI_RARE_DISEASES_INC. $29.3706/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060352857 CMS
Janssen Biotech, Inc. $14.4506/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988084349 CMS
Novartis Pharmaceuticals Corporation $15.5306/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992275365 CMS
Amgen Inc. $17.5706/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020696377 CMS
Novartis Pharmaceuticals Corporation $21.2105/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992275353 CMS
Celgene Corporation $18.1205/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015504815 CMS
Merck Sharp & Dohme LLC $23.7505/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048771443 CMS
PFIZER INC. $22.9905/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050669229 CMS
ABBVIE INC. $16.3705/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997638815 CMS
Amgen Inc. $10.8805/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020193889 CMS
Novartis Pharmaceuticals Corporation $19.7005/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992275369 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,883.25 152
PY2020 $1,895.57 113
PY2021 $2,584.15 143
PY2022 $4,558.44 158
PY2023 $3,338.16 162
PY2024 $4,152.90 157
PY2025 $2,690.05 133

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $2,344.76 4
PY2023 Principal investigator $9,423.25 2
PY2022 Principal investigator $350.00 1
PY2021 Principal investigator $831.25 2
PY2020 Principal investigator $14,993.25 3
PY2019 Principal investigator $23,071.51 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Sumitomo Pharma America, Inc. $637.88 04/17/2024 Non-covered Recipient Entity
LAKE CITY CANCER CARE LLC DBA CANCER CARE AND URO
RELUGOLIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (REPLACE-CV) No dispute reported 06/30/2026 1148431052
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $137.50 03/07/2024 Non-covered Recipient Entity
Lake City Cancer Care Llc
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice No dispute reported 06/30/2026 1155196573
Principal investigator 1 Sumitomo Pharma America, Inc. $784.69 01/24/2024 Non-covered Recipient Entity
LAKE CITY CANCER CARE LLC DBA CANCER CARE AND URO
RELUGOLIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (REPLACE-CV) No dispute reported 06/30/2026 1148431048
Principal investigator 1 Sumitomo Pharma America, Inc. $784.69 01/24/2024 Non-covered Recipient Entity
LAKE CITY CANCER CARE LLC DBA CANCER CARE AND URO
RELUGOLIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (REPLACE-CV) No dispute reported 06/30/2026 1148431050